Coenzyme A Stock Today

PPII Stock  USD 0.0002  0.00  0.00%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

High

 
High
 
Low
Coenzyme A is trading at 2.0E-4 as of the 28th of October 2025. This is a No Change since the beginning of the trading day. The stock's open price was 2.0E-4. Coenzyme A has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 30th of July 2025 and ending today, the 28th of October 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Coenzyme-A Inc. formulates and manufactures nutraceutical supplements, and skin and hair care products in the United States and internationally. Coenzyme-A Inc. was founded in 1998 and is based in Lynnwood, Washington. Coenzyme A operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 555.05 K outstanding shares. More on Coenzyme A

Coenzyme Stock Highlights

CEO PresidentNickoloaus Skouras
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Coenzyme A (PPII) is traded on OTCCE Exchange in USA and employs 1 people. Coenzyme A is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 111. Coenzyme A conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 555.05 K outstanding shares. Coenzyme A currently holds about 35.53 K in cash with (4 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Coenzyme A Probability Of Bankruptcy

Coenzyme Stock Against Markets

When determining whether Coenzyme A offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Coenzyme A's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Coenzyme A Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Coenzyme A Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Coenzyme A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coenzyme A. If investors know Coenzyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(35.31)
Revenue Per Share
2.652
Quarterly Revenue Growth
0.268
The market value of Coenzyme A is measured differently than its book value, which is the value of Coenzyme that is recorded on the company's balance sheet. Investors also form their own opinion of Coenzyme A's value that differs from its market value or its book value, called intrinsic value, which is Coenzyme A's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coenzyme A's market value can be influenced by many factors that don't directly affect Coenzyme A's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coenzyme A's value and its price as these two are different measures arrived at by different means. Investors typically determine if Coenzyme A is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.